BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24239465)

  • 1. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
    Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
    Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
    Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
    Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
    Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
    PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.
    Shim SR; Kim SJ; Kim SI; Cho DS
    World J Urol; 2017 May; 35(5):771-780. PubMed ID: 27665441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
    Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
    Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
    Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
    Pu Z; Wang Q; Xie H; Wang G; Hao H
    Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib.
    Beuselinck B; Vano YA; Oudard S; Wolter P; De Smet R; Depoorter L; Teghom C; Karadimou A; Zucman-Rossi J; Debruyne PR; Van Poppel H; Joniau S; Lerut E; Strijbos M; Dumez H; Paridaens R; Van Calster B; Schöffski P
    BJU Int; 2014 Jul; 114(1):81-9. PubMed ID: 24215209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
    Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis.
    Semeniuk-Wojtaś A; Lubas A; Stec R; Syryło T; Niemczyk S; Szczylik C
    Clin Genitourin Cancer; 2018 Jun; 16(3):e685-e693. PubMed ID: 29454639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of smoking on survival in renal cell carcinoma: a systematic review and meta-analysis.
    Xu Y; Qi Y; Zhang J; Lu Y; Song J; Dong B; Kong W; Xue W; Huang Y
    Tumour Biol; 2014 Jul; 35(7):6633-40. PubMed ID: 24699995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
    Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
    BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Prognostic Effect of Plasma Fibrinogen in Renal Cell Carcinoma: A Meta-Analysis.
    Tian Y; Hong M; Jing S; Liu X; Wang H; Wang X; Kaushik D; Rodriguez R; Wang Z
    Biomed Res Int; 2017; 2017():9591506. PubMed ID: 28154828
    [No Abstract]   [Full Text] [Related]  

  • 15. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
    Tsujino T; Komura K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Oide R; Minami K; Uehara H; Jeong SH; Taniguchi K; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Azuma H
    Ann Surg Oncol; 2017 Sep; 24(9):2787-2793. PubMed ID: 28643013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
    Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
    Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
    Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
    BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
    Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
    BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.
    Wang Z; Peng S; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y
    Clin Exp Med; 2018 May; 18(2):165-175. PubMed ID: 29362922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis.
    Xie Y; Chen L; Ma X; Li H; Gu L; Gao Y; Fan Y; Zhang Y; Zhang X
    Sci Rep; 2017 Mar; 7():44281. PubMed ID: 28287186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.